[Edaily Starin Reporter Choi Hee-jae ] Lee Jung-jae, the lead actor in the global hit "Squid Game," and director Hwang Dong-hyuk will meet with audiences at a special Q&A session for "Hope." From left: Director Hwang Dong-hyuk, Lee Jung-jae, and Jung Ho-yeon (Photo = E-Daily DB) Distributor Plus M Entertainment announced on the 20th, “We will host a special GV (Q&A session) featuring Director Hwang Dong-hyuk, actor Lee Jung-jae, and actress Jung Ho-yeon.” The event will take place on the 22nd at Megabox COEX following the 6:35 p.m. screening. With writer Kim Se-yoon serving as moderator, this GV holds special significance as the three lead actors—who previously collaborated on the global phenomenon *Squid Game*—will gather in one place. Previously, Jeong Ho-yeon rose to global stardom after leaving a powerful impression as Kang Sae-byeok in Season 1 of *Squid Game*. (Photo courtesy of Plus M Entertainment) During the GV, the cast will share a variety of stories—including their impressions of *Hope*, behind-the-scenes anecdotes from the set, and Jeong Ho-yeon’s efforts to bring her character “Seong-ae” to life—to spend a meaningful time with the audience. Tickets for this special GV, which heralds the welcome reunion of Director Hwang Dong-hyuk, Lee Jung-jae, and Jung Ho-yeon, will go on sale via the Megabox website and app. “Hope” is a science fiction feature film directed by Na Hong-jin—known for “The Chaser” and “The Yellow Sea”—marking his return to the genre 10 years after “The Wailing.” The story begins when Beom-seok (played by Hwang Jung-min), the head of the Hopo Port branch office located in the Demilitarized Zone, hears reports from local youths about a tiger sighting. As the entire village goes on high alert, he is confronted with a reality that defies belief. The film stars Hwang Jung-min, Jo In-sung, and Jung Ho-yeon, alongside Taylor Russell, Cameron Britton, Alicia Vikander, and Michael Fassbender.
IMM Private Equity (IMM PE), a domestic private equity fund (PEF) manager, has begun taking steps to buy time to exit its investment in Hanssem. With acquisition financing totaling around 800 billion …
Neopharm CO., LTD.(092730), a South Korean derma-beauty specialist, is seeking to expand into a global derma-beauty brand by leveraging “Atopam,” a skincare brand specializing in sensitive skin condit…
(Graphic: ChatGPT)
A domestically developed treatment with a new mechanism of action is set to enter the Korean dry eye market, which has long been dominated by artificial tears. This follows the …